100 related articles for article (PubMed ID: 15507710)
1. Pseudovirions as specific tools for investigation of virus interactions with cells.
Sapp M; Selinka HC
Methods Mol Biol; 2005; 292():197-212. PubMed ID: 15507710
[TBL] [Abstract][Full Text] [Related]
2. Generation and applications of HPV pseudovirions using vaccinia virus.
Sapp M; Selinka HC
Methods Mol Med; 2005; 119():463-82. PubMed ID: 16350418
[TBL] [Abstract][Full Text] [Related]
3. Generation and neutralization of pseudovirions of human papillomavirus type 33.
Unckell F; Streeck RE; Sapp M
J Virol; 1997 Apr; 71(4):2934-9. PubMed ID: 9060652
[TBL] [Abstract][Full Text] [Related]
4. Infectious human papillomavirus type 18 pseudovirions.
Stauffer Y; Raj K; Masternak K; Beard P
J Mol Biol; 1998 Oct; 283(3):529-36. PubMed ID: 9784363
[TBL] [Abstract][Full Text] [Related]
5. [Construction and identification of the replication-deficient recombinant vaccinia virus co-expressing HPV type 16 L1 and L2 proteins].
Han L; Ren J; Liang Y; Tian H; Zhi H; Luo W; Lu Z; Wei L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):256-60. PubMed ID: 12665934
[TBL] [Abstract][Full Text] [Related]
6. In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids.
Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 1998 Dec; 72(12):10298-300. PubMed ID: 9811779
[TBL] [Abstract][Full Text] [Related]
7. [Construction and identification of non-replication recombinant vaccinia virus co-expressing human papillomavirus type 16 L1/L2/E6/E7 proteins].
Huang W; Tian HW; Ren J; Fan JT; Zhao L; Bian T; Lu ZH; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):240-3. PubMed ID: 16261206
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate.
Combita AL; Touzé A; Bousarghin L; Sizaret PY; Muñoz N; Coursaget P
FEMS Microbiol Lett; 2001 Oct; 204(1):183-8. PubMed ID: 11682199
[TBL] [Abstract][Full Text] [Related]
9. Fluorescently Labeled Human Papillomavirus Pseudovirions for Use in Virus Entry Experiments.
Samperio Ventayol P; Schelhaas M
Curr Protoc Microbiol; 2015 May; 37():14B.4.1-22. PubMed ID: 26344217
[TBL] [Abstract][Full Text] [Related]
10. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1.
Zhou JA; McIndoe A; Davies H; Sun XY; Crawford L
Virology; 1991 Mar; 181(1):203-10. PubMed ID: 1847256
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of delivery of DNA to cells by bovine papillomavirus type-1 L1/L2 pseudovirions.
Liu Y; Frazer IH; Liu WJ; Liu XS; McMillan N; Zhao KN
Appl Microbiol Biotechnol; 2001 Jul; 56(1-2):150-6. PubMed ID: 11499923
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
13. Generation of HPV pseudovirions using transfection and their use in neutralization assays.
Buck CB; Pastrana DV; Lowy DR; Schiller JT
Methods Mol Med; 2005; 119():445-62. PubMed ID: 16350417
[TBL] [Abstract][Full Text] [Related]
14. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.
Zhou J; Sun XY; Stenzel DJ; Frazer IH
Virology; 1991 Nov; 185(1):251-7. PubMed ID: 1656586
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.
El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P
J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077
[TBL] [Abstract][Full Text] [Related]
16. Further evidence that papillomavirus capsids exist in two distinct conformations.
Selinka HC; Giroglou T; Nowak T; Christensen ND; Sapp M
J Virol; 2003 Dec; 77(24):12961-7. PubMed ID: 14645552
[TBL] [Abstract][Full Text] [Related]
17. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1.
Zhao KN; Sun XY; Frazer IH; Zhou J
Virology; 1998 Apr; 243(2):482-91. PubMed ID: 9568045
[TBL] [Abstract][Full Text] [Related]
18. Immunological analyses of human papillomavirus capsids.
Giroglou T; Sapp M; Lane C; Fligge C; Christensen ND; Streeck RE; Rose RC
Vaccine; 2001 Feb; 19(13-14):1783-93. PubMed ID: 11166904
[TBL] [Abstract][Full Text] [Related]
19. DNA binding of L1 is required for human papillomavirus morphogenesis in vivo.
Schäfer F; Florin L; Sapp M
Virology; 2002 Mar; 295(1):172-81. PubMed ID: 12033775
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.
Heino P; Dillner J; Schwartz S
Virology; 1995 Dec; 214(2):349-59. PubMed ID: 8553535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
